Artículo de revisión
Evidencia disponible acerca del uso del agonista β3-adrenoceptor selectivo mirabegrón para el tratamiento de la vejiga hiperactiva
Evidence available on the use of the selective β3-adrenoceptor agonist mirabegron for the treatment of overactive bladder
a Servicio de Urología, Hospital Universitario de Getafe, Madrid, España
b Servicio de Ginecología, St Mary's Hospital, Imperial College, Londres, Reino Unido
c Servicio de Urología, New York University Langone Medical Center, Nueva York, Estados Unidos
d Departamento Médico, Astellas Pharma Europe Ltd, Chertsey and Department of Urology, Ealing Hospital, Londres, Reino Unido
Leído
1091
Vecesse ha leído el artículo
287
Total PDF
804
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 10 | 0 | 3 | 3 |
| 2025 8 | 1 | 0 | 1 |
| 2024 9 | 2 | 0 | 2 |
| 2023 3 | 4 | 1 | 5 |
| 2022 8 | 1 | 2 | 3 |
| 2020 1 | 4 | 4 | 8 |
| 2018 10 | 1 | 2 | 3 |
| 2018 2 | 16 | 5 | 21 |
| 2018 1 | 16 | 6 | 22 |
| 2017 12 | 23 | 0 | 23 |
| 2017 11 | 19 | 4 | 23 |
| 2017 10 | 29 | 4 | 33 |
| 2017 9 | 12 | 6 | 18 |
| 2017 8 | 33 | 11 | 44 |
| 2017 7 | 31 | 3 | 34 |
| 2017 6 | 18 | 3 | 21 |
| 2017 5 | 28 | 8 | 36 |
| 2017 4 | 33 | 5 | 38 |
| 2017 3 | 25 | 18 | 43 |
| 2017 2 | 18 | 4 | 22 |
| 2016 1 | 23 | 2 | 25 |
| 2016 12 | 39 | 14 | 53 |
| 2016 11 | 63 | 14 | 77 |
| 2016 10 | 57 | 11 | 68 |
| 2016 9 | 35 | 5 | 40 |
| 2016 8 | 38 | 5 | 43 |
| 2016 7 | 23 | 5 | 28 |
| 2016 6 | 28 | 8 | 36 |
| 2016 5 | 23 | 14 | 37 |
| 2016 4 | 22 | 9 | 31 |
| 2016 3 | 25 | 13 | 38 |
| 2016 2 | 19 | 14 | 33 |
| 2015 1 | 21 | 18 | 39 |
| 2015 12 | 16 | 12 | 28 |
| 2015 11 | 17 | 14 | 31 |
| 2015 10 | 0 | 1 | 1 |
| 2015 9 | 0 | 3 | 3 |
| 2015 8 | 0 | 1 | 1 |
| 2015 6 | 1 | 1 | 2 |
| 2015 4 | 0 | 1 | 1 |
| 2015 2 | 0 | 2 | 2 |
| 2015 1 | 1 | 0 | 1 |
| 2014 12 | 0 | 2 | 2 |
| 2014 11 | 1 | 0 | 1 |
| 2014 9 | 1 | 0 | 1 |
| 2014 5 | 0 | 1 | 1 |
| 2014 4 | 0 | 4 | 4 |
| 2014 3 | 0 | 3 | 3 |
| 2014 2 | 1 | 1 | 2 |
| 2014 1 | 9 | 4 | 13 |
| 2013 12 | 18 | 8 | 26 |
| 2013 11 | 9 | 6 | 15 |
| 2013 10 | 0 | 2 | 2 |
Mostrar todo
